Due to a manufacturing problem during the filling of the cartridges, individual products of the above mentioned batches of "NovoMix® 30 FLexPen®" may…

The marketing authorization holder has informed its supplied customers in a letter dated 11.10.2013 that complaints have arisen describing the…

On October 8, 2013, the marketing authorization holder informed its customers that injection vials may have an externally invisible defect under the…

During a routine quality check, a small number of prefilled syringes were found to contain particles consisting mainly of cellulose fibers. The…

The marketing authorization holder has informed its supplied customers in a letter dated 13.09.2013 that investigations have shown that the optimal…

The marketing authorization holder informed its supplied customers in a letter dated August 22, 2013, that visible particles were detected in some…

B. Braun Austria Ges.m.b.H. has informed its supplied customers in a letter dated August 5, 2013, that a customer complaint has informed the marketing…

The marketing authorization holder informed its supplied customers in a letter dated July 9, 2013, that in the course of quality assurance measures it…

The distribution partner "sanofi-aventis GmbH" informed its supplied customers in a letter dated 04.07.2013 that the retained samples of the above…

The marketing authorization holder has informed its supplied customers in a letter dated June 19, 2013, that due to a manufacturing problem and the…